The 34th Annual Meeting of the Japanese Vascular Biology and Medicine Organization (JVBMO 2026)
Abstract Submission, Modifications, and Deletions
To register, modify, or delete your abstract, please click the link below to create a My Page and proceed to the abstract registration page:
Overview
| Date | November 14-15,2026 |
| Venue |
Ogawa Hideoki Hall, Bldg. 7, Juntendo University (Hongo-Ochanomizu Campus) 2-2-5 Hongo, Bunkyo City, Tokyo 113-8421, Japan https://en.juntendo.ac.jp/access.html https://maps.app.goo.gl/KFMw5dkawcSEi52z8 |
| Main Theme | TOGETHER: Power of Diversity Connecting Generations, Fields and Basic to Clinical Research |
| President of the conference |
Tetsuro Watabe, Ph.D. Professor, Department of Biochemistry Vice Dean for Research, School of Dentistry Institute of Science Tokyo |
→ scrollable
CALL for ABSTRACT
Abstract Submission Period:
April 15, 2026 (Wednesday) – June 30, 2026 (Tuesday)
Presentation Format:
Poster Presentation
* When submitting an abstract from the English page, only poster presentation can be selected.
Abstract Categories:
Please select the most appropriate category for your abstract from the list below. This will assist with session organization.
| 01. Aging/Anti-aging | 18. Lymph angiogenesis/Lymphatic vessels |
| 02. Angiogenesis/Vascular development | 19. New Technologies |
| 03. Atherosclerosis/Arteriosclerosis | 20. NO and oxidative stress |
| 04. Biomedical engineering | 21. Mechanotransduction |
| 05. Cell differentiation/Proliferation | 22. Metabolic syndrome/Obesity |
| 06. Computational model | 23. Pulmonary hypertension |
| 07. Clinical studies | 24. Signal transduction |
| 08. Diabetes/Diabetic vascular complication | 25. Single cell RNA sequencing |
| 09. Epigenetics/non-coding RNA | 26. Stem cells/Progenitor cells |
| 10. Extracellular Vesicles | 27. Stroke/Neurovascular disease |
| 11. Genetics/Transcription | 28. Thrombosis |
| 12. Heart failure | 29. Transcriptional regulation |
| 13. Hypertension | 30. Translational research |
| 14. Hypoxia | 31. Tumor angiogenesis/Cancer biology |
| 15. Inflammation/Innate immunity | 32. Vascular imaging |
| 16. Lipid mediator | 33. Vascular function |
| 17. Lipid metabolism/Lipoprotein | 34. Others |
Abstract Submission Guidelines:
Language & Word Count Limitations
- Title: English (up to 25 words, 150 characters)
- Abstract: English (up to 280 words, 1,800 characters)
- Presentation Poster: English
Important Submission Notes
- The word count shown in Microsoft Word may be inaccurate due to the use of full-width characters; please verify the word count using the submission system.
- Please use half-width characters for English letters, numbers and spacing.
- Text formatting: bold, italics, underline, superscript (e.g., Na+), or subscript (e.g., H2O) will not be preserved during copy-pasting. Please use the editing toolbar to apply any necessary formatting after pasting.
- Images, photographs, and charts cannot be attached.
- For any technical issues such as garbled characters, please contact support at the provided email.
Submission & Revision Process
- After clicking "Save", review your details in the next screen and confirm by clicking "Save Confirmed".
- To submit, click the "Submit" button and confirm your details before selecting "Submit Confirmed".
- After submission, check your abstract for errors under "My Page" > "Abstracts" > "Abstract List".
- You may revise or delete your abstract at any time during the registration period. Use your login ID and password to make changes.
Deadline Reminders
- Submissions and revisions are likely to be more difficult close to the deadline, so we recommend submitting early.
- Even if you do not need to revise your abstract, please confirm your submission under "My Page" > "Abstracts" > "Abstract List".
Personal Information Handling Policy:
Personal information submitted through the abstract registration and event participation process will be used for registration, notifications, abstract compilation, and inquiries. Information such as your name, affiliation, and contact details will be shared with the contracted publisher for abstract book editing and distribution. If you wish to limit the disclosure of your personal information, please contact the Management Secretariat.
Conflict of Interest (COI) Disclosure:
A COI is required for all presentations. This should be placed at the end for poster presentations. The COI disclosure does not require verbal explanation.
Acceptance & Notification:
The final decision regarding acceptance and presentation time will be made by the organizers and sent to the registered email address. Notifications will also be posted on the event website.
Contact
If you have any questions, please contact JVBMO 2026 Management Secretariat at Email: jvbmo2026@zenith-j.co.jp